Corium International, Inc.
(NASDAQ : CORI)

( )
CORI PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-1.04%128.010.6%$1267.13m
MRKMerck & Co., Inc.
0.13%74.600.6%$1104.56m
PFEPfizer Inc.
-1.52%42.080.9%$1098.58m
BMYBristol-Myers Squibb Company
-1.19%49.131.4%$906.46m
ABBVAbbVie, Inc.
0.01%85.512.2%$613.58m
LLYEli Lilly and Company
-0.27%116.771.0%$601.40m
NVSNovartis AG Sponsored ADR
0.08%87.940.2%$199.13m
AZNAstraZeneca PLC Sponsored ADR
-0.89%35.791.3%$185.27m
GSKGlaxoSmithKline plc Sponsored ADR
-1.67%38.400.2%$154.19m
NVONovo Nordisk A/S Sponsored ADR Class B
-0.70%46.870.1%$70.75m
SNYSanofi Sponsored ADR
-0.07%42.210.2%$41.43m
LCILannett Company, Inc.
-3.21%7.5337.0%$12.05m
AKTXAkari Therapeutics Plc Sponsored ADR
-4.00%1.921.7%$0.06m
EPIXESSA Pharma Inc
3.72%3.900.1%$0.02m

Company Profile

Corium International, Inc. is a commercial stage biopharmaceutical company, which develops, manufactures and commercializes pharmaceutical products. The company development platforms enable transdermal delivery of large molecules or biologics, including vaccines, peptides and proteins, as well as small molecules that are otherwise difficult to deliver in a transdermal dosage form. The firm offers its products under the brands Corplex and MicroCor. Corium International was founded by Gary W. Cleary and Adrian L. Faasse, Jr. in 1999 and is headquartered in Menlo Park, CA.